General Information of the Compound
| Compound ID |
CP0851151
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,3R,4S,E)-5-(2-(6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-2-methylhydrazono)hexane-1,2,3,4,6-pentaol
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H27N7O9
|
||||||||||||||||||
| Molecular Weight |
473.443
|
||||||||||||||||||
| Canonical SMILES |
CN(/N=C(\CO)[C@H](O)[C@@H](O)[C@@H](O)CO)c1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H27N7O9/c1-23(22-6(2-25)10(29)11(30)7(28)3-26)17-20-14(18)9-15(21-17)24(5-19-9)16-13(32)12(31)8(4-27)33-16/h5,7-8,10-13,16,25-32H,2-4H2,1H3,(H2,18,20,21)/b22-6+/t7-,8+,10-,11-,12+,13+,16+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QZCGMRPYAKHLLN-GQMGTPALSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3